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Summary
 
The transcription factors encoded by the 
 
E2A
 
 and early B cell factor (
 
EBF
 
) genes are required
for the proper development of B lymphocytes. However, the absence of B lineage cells in
 
E2A
 
- and 
 
EBF
 
-deficient mice has made it difficult to determine the function or relationship
between these proteins. We report the identification of a novel model system in which the role
of E2A and EBF in the regulation of multiple B lineage traits can be studied. We found that the
conversion of 70Z/3 pre-B lymphocytes to cells with a macrophage-like phenotype is associ-
ated with the loss of E2A and EBF. Moreover, we show that ectopic expression of the E2A
protein E12 in this macrophage line results in the induction of many B lineage genes, including
EBF, IL7R
 
a
 
, 
 
l
 
5, and Rag-1, and the ability to induce 
 
k
 
 light chain in response to mitogen.
Activation of EBF may be one of the critical functions of E12 in regulating the B lineage phe-
notype since expression of EBF alone leads to the activation of a subset of E12-inducible traits.
Our data demonstrate that, in the context of this macrophage line, E12 induces expression of
EBF and together these transcription factors coordinately regulate numerous B lineage–associ-
ated genes.
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B
 
lymphocytes, the cellular source of antibodies, develop
from lineage unrestricted progenitors in the fetal liver
and adult bone marrow (1). Commitment of multipotent
progenitors to the B lineage is associated with their ability
to proliferate in response to IL7, first in the presence of
stromal cells and then alone (2, 3). In addition, committed
B lineage cells can be identified by the expression of a
number of B lineage–associated genes and rearrangement
of the Ig heavy chain V, D, and J gene segments (4). The
most immature, pro-B cells express the recombinase acti-
vating genes, Rag-1 and Rag-2, which function in the site-
specific recombination of Ig gene segments (5–8). Once a
functional Ig protein is synthesized it is expressed on the
cell surface in association with the surrogate light chain
proteins 
 
l
 
5 and VpreB and the signal transducing proteins
Ig
 
a
 
 (mb-1) and Ig
 
b
 
 (B29) which are also expressed in pro-B
lymphocytes (9, 10). Expression of a functional Ig heavy
chain and its associated proteins is required for the proper
development of B cells since targeted inactivation of any of
the genes whose products are required for Ig rearrange-
ment or expression leads to an arrest before the develop-
ment of pre-B lymphocytes (reviewed in reference 11).
The majority of Ig
 
k
 
 and Ig
 
l
 
 light chain gene rearrange-
ments occur in pre-B lymphocytes (12, 13).
The development of mature B lymphocytes from multi-
potent progenitors requires the coordinated action of a
number of transcriptional regulators, including the products
of the 
 
Scl/tal
 
 (14), 
 
Ikaros
 
 (15), 
 
Pu.1
 
 (16, 17), 
 
E2A
 
 (18, 19),
early B cell factor (
 
EBF
 
;
 
1
 
 reference 20), and B cell–specific
activator protein (
 
BSAP/Pax-5
 
) genes (21). The 
 
SCL/tal
 
,
 
Ikaros
 
, and 
 
Pu.1
 
 genes function in the development of mul-
tipotent progenitors, whereas 
 
E2A
 
, 
 
EBF
 
, and 
 
Pax-5
 
 are re-
quired specifically at the time of or after commitment to the
B lineage. In the bone marrow of 
 
Pax-5
 
–deficient mice, B
cell development is arrested after the initiation of D-J
 
H
 
 re-
arrangements but before V-DJ
 
H
 
 rearrangement (21). These
B lineage progenitors express most pro-B cell–associated
genes and respond to IL7 in the presence of stromal cells but
fail to differentiate to more mature B cell stages (22). Mice
that do not express the 
 
E2A
 
 or 
 
EBF
 
 gene show a block in B
lineage progression at an earlier developmental stage, before
the initiation of Ig gene rearrangement and expression of
most B lineage–associated genes (18–20). The requirements
 
1
 
Abbreviations used in this paper:
 
 bHLH, basic helix-loop-helix; c-fms, mac-
rophage colony-stimulating factor; EBF, early B cell factor; EMSA, elec-
trophoretic mobility shift assay; RT, reverse transcriptase.
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for E2A and EBF in regulating B cell development are en-
tirely unknown since deletion of most potential target genes
results in an arrest at a later developmental stage than that
observed in the absence of either factor (see reference 11).
The 
 
E2A
 
 gene encodes two basic helix-loop-helix
(bHLH) transcription factors, E12 and E47, which arise
through alternative splicing of exons encoding the bHLH
domain (23, 24). E12 and E47 share 
 
.
 
80% sequence iden-
tity and both proteins bind to the canonical E-box motif,
CANNTG, found in the regulatory regions of many B lin-
eage genes, including the Ig heavy and light chain enhanc-
ers (25, reviewed in 26). These proteins diverge primarily
in the HLH motif, which mediates dimerization, and the
basic region, which is required for binding to DNA (27,
28). Recent studies have demonstrated that both E12 and
E47 are required for the proper development of B lineage
cells indicating that these proteins are not functionally re-
dundant (29). However, both proteins have the ability to
commit lymphocytes to the B lineage.
E12 and E47 are class I bHLH proteins that are expressed
in a wide range of cell types and can form heterodimers
with cell-type specific, class II bHLH proteins. E2A pro-
teins are known to play a central role in cell fate decisions
as the dimerizing partners for the lineage-specific myogenic
factors MyoD, Myf5, and myogenin, and the neurogenic/
pancreatic factor, NeuroD/Beta2 (30–33). However, dur-
ing B lymphocyte development no lineage-specific bHLH
partners for E2A have been identified and these proteins
may function as homodimers (34, 35). Therefore, the spe-
cific B lineage defect in E2A-deficient mice may reflect the
nonredundant functions of E2A homodimers in these cells.
E2A proteins also form heterodimers with class V HLH
proteins, referred to as Id proteins, which lack a functional
basic region and therefore inhibit the ability of E2A to bind
DNA and activate transcription (36, 37). Four Id genes,
 
Id1–4
 
, have been identified in the mammalian genome.
The Id gene products show overlapping and distinct distri-
butions in the mouse embryo and adult tissues. Mice carry-
ing an Id1 transgene expressed in B lineage cells, show an
arrest in B cell development consistent with the require-
ment for E2A proteins (38). Within the hematopoietic sys-
tem, Id proteins have been detected in both lymphoid and
myeloid cells and shown to be important regulators of my-
eloid differentiation (39–43).
EBF is a novel transcription factor that is expressed in
adipocytes, olfactory neurons, and all B lineage cells, with
the exception of terminally differentiated plasma cells (44,
45). EBF contains a COOH-terminal domain that is re-
lated to the HLH domain and mediates EBF homodimer
formation (46). However, this HLH-like domain does not
appear to mediate strong dimerization with class I bHLH
proteins (47). DNA binding by EBF homodimers is medi-
ated by an NH
 
2
 
-terminal cysteine-rich region that contains
a potential zinc coordination motif (46). This protein mod-
ule can bind DNA as a monomer or homodimer on cor-
rectly spaced DNA half-sites.
Both 
 
E2A
 
- and 
 
EBF
 
-deficient mice are blocked at an
early stage of B cell development (Fraction A). However,
the functions of E2A and EBF in this developmental pro-
cess have been difficult to deduce in mutant mice owing to
the lack of B cell progenitors. To gain insight into how
E2A and EBF control early B cell development, we have
used a novel cell line model in which the ability of these
factors to regulate B lineage–associated gene expression can
be studied. We demonstrate that the expression of E12 in
the 70Z/3 macrophage cell line results in the induction of a
large number of B lineage–associated genes including EBF,
 
l
 
5, IL7R
 
a
 
, and Rag-1, and the ability to induce 
 
k
 
 light
chain in response to mitogens. The induction of most B
lineage traits requires the NH
 
2
 
-terminal transactivation do-
mains of E12 indicating that this phenotypic conversion is
due to transcriptional activation of target genes by E12. In
addition, we show that expression of EBF, in the absence
of E12, leads to the activation of a subset of E12-inducible
genes. Taken together, our data demonstrate that, in the
context of this macrophage line, E12 induces the expres-
sion of EBF and that these transcription factors coordi-
nately regulate numerous B lineage–associated genes.
 
Materials and Methods
 
Cell Lines and Culture Conditions.
 
All cell lines were main-
tained in Opti-MEM containing 5% FBS, 5.5 
 
3
 
 10
 
2
 
5
 
 M 
 
b
 
-mer-
captoethanol, 100 
 
m
 
g/ml penicillin, and 100 
 
m
 
g/ml streptomy-
cin. In some experiments the cells were cultured in the presence
of 25 
 
m
 
g/ml LPS (GIBCO BRL, Gaithersburg, MD) for 36 h.
 
Protein Extracts and Electrophoretic Mobility Shift Assays.
 
Nuclear ex-
tracts  were prepared as described (48). Protein concentrations
were determined using Bio-Rad’s protein assay reagent (Bio-Rad
Laboratories, Hercules, CA). Double-stranded DNA probes were
end labeled using T4 polynucleotide kinase and purified over a
G25–Sepharose column. Electrophoretic mobility shift assays
(EMSA) using the 
 
m
 
E5, Pax-5, and Oct oligos were performed as
described previously (49). The DNA–protein complexes were re-
solved by electrophoresis through a 5% polyacrylamide gel con-
taining 45 mM Tris, 45 mM boric acid, and 1 mM EDTA, dried,
and then exposed to autoradiographic film at 
 
2
 
70
 
8
 
C. EMSA us-
ing the EBF probe were performed by incubating 10 
 
m
 
g nuclear
extract in a binding buffer containing 10 mM Hepes, pH 7.9, 70
mM KCl, 70 mM ZnCl, 2.5 mM MgCl
 
2
 
, 1 mM dithiothreitol, 1
mM EDTA, 4% glycerol, 10 
 
m
 
g BSA and 0.2 
 
m
 
g poly(dIC-dIC)
for 15 min at room temperature followed by 15 min at 4
 
8
 
C. The
DNA–protein complexes were resolved by electrophoresis through
a 5% polyacrylamide gel containing 25 mM Tris, 190 mM glycine,
and 1 mM EDTA at 4
 
8
 
C as described (50). The sequences of the
 
m
 
E5 (51), EBF (50), Pax-5 (52), and Oct (53) oligonucleotides have
been published previously.
 
Immunoprecipitations.
 
10
 
7
 
 cells were starved of methionine by
incubating the cells for 1 h in 2 ml of minus methionine DME
containing 10% dialyzed calf serum, 5.5 
 
3
 
 10
 
2
 
5
 
 M 
 
b
 
-mercapto-
ethanol, 100 
 
m
 
g/ml penicillin, 100 
 
m
 
g/ml streptomycin, and 10 mM
glutamine in a humidified 37
 
8
 
C incubator containing 5% CO
 
2
 
.
[
 
35
 
S]methionine (ICN) was added at a final concentration of 0.5
 
m
 
Ci/ml and the cells were incubated for 1 h with occasional agi-
tation. Total cellular extracts were prepared in 500 
 
m
 
l of RIPA
lysis buffer. The extracts were precleared for 1 h at 4
 
8
 
C with a
50-
 
m
 
l packed volume of protein A–Sepharose after which the su-
pernatant was transferred to a new tube containing 5 
 
m
 
l of poly-
clonal rabbit anti-Id2 antibody (Santa Cruz Biotechnology Inc., 
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Santa Cruz, CA) and rotated at 4
 
8
 
C for 1 h. A further 1 h incuba-
tion was carried out after the addition of 25 
 
m
 
l of protein A–Seph-
arose. The antigen-antibody-Sepharose conjugates were washed
4
 
3 
 
with 1 ml of lysis buffer and dissociated by the addition of an
equal volume of 2
 
3
 
 SDS–polyacrylamide gel loading buffer and
boiling for 10 minutes. The immunoprecipitated proteins were
electrophoresed through a 12% SDS–polyacrylamide gel. The
gels were fixed in 10% methanol/10% acetic acid for 10 min and
then incubated for 30 min in 1 M sodium salicylate before being
dried and exposed to autoradiographic film for 12 h.
 
Western Blot Analysis.
 
20 
 
m
 
g of nuclear extract was electro-
phoresed through an 8% SDS–polyacrylamide gel and transferred
to Immobulon membranes. The membranes were stained with
amido black for 2 min and subsequently washed with 10% meth-
anol and 10% acetic acid in order to determine that equivalent
amounts of nuclear protein had been transferred in each lane. The
membranes were blocked for 1 h at room temperature in TBST
(50 mM Tris, pH 7.5, 150 mM NaCl, and 0.5% Tween-20) con-
taining 5% milk powder. The blots were then incubated for 2 h
in TBST containing one of the following antibodies: 1:500 dilution
of anti-E12 (Ab 382.6; PharMingen) or 1:250 dilution of anti-E47
(Ab 32.1; PharMingen). The blots were washed 3
 
3
 
 for 15 min in
TBST before addition of HRP-conjugated goat anti–mouse IgG at
a dilution of 1:15,000 (GIBCO BRL) for 1 h. The blots were
washed 3
 
3
 
 for 15 min in TBST and developed using the ECL de-
tection system (Amersham Pharmacia Biotech Inc., Piscataway, NJ).
 
Creation of Stable Cell Lines and Plasmid Construction.
 
3 
 
3
 
 10
 
7
 
cells were resuspended in 500 
 
m
 
l culture media containing 10 
 
m
 
g
of the pH
 
b
 
APneo, pH
 
b
 
APneoE12, or pH
 
b
 
APneoEBF plasmids
and electroporated at 950 
 
m
 
F and 250 volts using a Gene Pulser
(Bio-Rad Laboratories). The electroporated cells were cultured
under limiting dilution conditions for 24 h before the addition of
1 mg/ml G418 to the culture media. After 2 to 3 wk, individual
clones were harvested and expanded in 10- or 15-cm culture
dishes. Both adherent and nonadherent cells were collected at
each passage in order to avoid selection based on adherence. The
pH
 
b
 
APneo plasmid was obtained from Dr. S. Hedrick (University
of California, San Diego, CA) and contains the neomycin resistance
gene driven by the SV40 early promoter with cloning sites down-
stream of the human 
 
b
 
-actin promoter (54). The pH
 
b
 
APneoE12
expression construct was created by ligation of an E12, EcoRI-
HindIII fragment, into the BamHI site of pH
 
b
 
APneo after treat-
ment of both digested fragments with Klenow and was generously
donated by Dr. G. Bain. The pHbAPneoE12 bHLH construct
was created by PCR amplification of a 395-bp fragment spanning
nt 886–1279 (as numbered in reference 24) using primers bHLH
for: 5
 
9
 
-GATCCCGGGCGGCTGACCACTCG-3
 
9
 
 and HLH rev:
5
 
9
 
-CCATCTAGAGCTGAAAGCACCATCTG-3
 
9
 
. This PCR
fragment was digested with XbaI and cloned into pSS-Flag digested
with XbaI and XmaI and designated as pSS-E12 bHLH. pSS-E12
bHLH was digested with XbaI, made blunt with Klenow, and sub-
sequently digested with HindIII. This fragment was cloned into
pH
 
b
 
APneo digested with BamHI, made blunt with Klenow, and
subsequently digested with HindIII resulting in pH
 
b
 
APneoE12
bHLH. The pH
 
b
 
APneoEBF construct was created by ligation of a
SalI and HindIII fragment of the rat Olf/EBF cDNA (provided by
Dr. R. Reed, Johns Hopkins University, Baltimore, MD) into
pH
 
b
 
APneo digested with SalI and HindIII.
 
FACS
 
Ò
 
 Analysis.
 
1 
 
3
 
 10
 
6
 
 cells were stained as described pre-
viously (29). Cells were analyzed on a FACScan
 
Ò (Becton Dick-
inson, Mountain View, CA) using the CellQuest software pack-
age. Live cells were gated on the basis of forward vs. side scatter.
All antibodies were purchased from PharMingen (San Diego,
CA) and include anti-Mac-1(FITC), anti-IgM(biotin), anti-k(bi-
otin), anti-Ly6A(PE), and the secondary reagent streptavidin (PE).
RNA Isolation and Northern Blot Analysis. 10 mg of total RNA
was isolated by Trizol (GIBCO BRL) and separated through a
0.75% agarose gel buffered with 18 mM Na2HPO4, 2 mM
NaH3PO4, and 6% formaldehyde after incubation for 5 min at
658C in the same buffer containing 50% formamide. The gel was
washed extensively with dH2O and the RNA was transferred to
nytran membrane by capillary action using 103 SSC. The blot
was hybridized with random primed, 32P-labeled gene-specific
probes in 50% formamide, 53 SSC, 0.15% SDS, 13 Denhardt’s,
and 10% dextran sulfate containing 100 mg/ml heat-denatured
herring sperm DNA at 428C overnight. The blots were washed
23 for 30 min at 428C in 23 SSC/0.2% SDS and 23 15 min at
608C in 0.23 SSC/0.2% SDS before exposure to autoradio-
graphic film at 2708C for 12–24 h.
Reverse Transcriptase Polymerase Chain Reaction Assays. 2 mg of
total RNA was treated with 10 U DNAse (Boehringer Mannheim
Corp., Indianapolis, IN) at 378C for 10 min in reverse tran-
scriptase (RT) buffer (GIBCO BRL) followed by heat inactivation
at 708C for 10 min. DNA-free RNA was reverse transcribed and
amplified as described previously (29). PCR reactions to detect
Rag-1 and Ikaros were amplified for 25 cycles. PCR reactions to
detect actin were amplified for 13 cycles of 1 min at 948C, 1 min
at 598C, and 1 min at 728C. The sequence of the Rag-1, actin,
and Ikaros PCR primers have been published previously (18, 55).
Results
The Transition of 70Z/3 Pre-B Lymphocytes to the Macro-
phage Phenotype Is Associated with a Loss of the E2A and EBF
Transcription Factors. A number of B lineage cell lines and
a subpopulation of chronic lymphocytic and acute leuke-
mias have been shown to lose some of their B lineage char-
acteristics and acquire characteristics of macrophages (56–
63). The 70Z/3 pre-B line is unique among these lineage
switching cells in that it undergoes spontaneous alterations
in vitro which result in the emergence of macrophage-like
cells (56). Previous studies have suggested that this switch
occurs through the reproducible loss of sets of B lineage
genes (64). We reasoned that the loss of B lineage charac-
teristics may be the result of a loss of key regulators of B
lineage genes. Therefore, this cell line would provide novel
insights as to which transcriptional regulators are involved
in the maintenance of the B lineage program.
The E2A, EBF, and Pax-5 transcription factors have
been shown to be required for progression through the ear-
liest stages of B cell development. To determine whether
these proteins were expressed in the 70Z/3 pre-B or mac-
rophage cell lines we examined the ability of nuclear ex-
tracts to complex with specific DNA binding sites by
EMSA. Nuclear extract from the pre-B line contained pro-
teins that bound to the E2A-binding site (E-box) in the
mE5 oligo (Fig. 1 A). This complex was competed by an
excess of unlabeled mE5 and was supershifted with anti-
bodies specific for the E2A proteins (data not shown). By
contrast, the 70Z/3 macrophage line did not show specific
binding to the mE5 probe, indicating an absence of func-
tional E2A (Fig. 1 A). The pre-B cell extract also contained
proteins that bound specifically to the EBF- and the Pax-702 Induction of B Lineage Genes by E12
5–binding sites (Fig. 1 A). The macrophage nuclear extract
lacked the EBF complex although a faster mobility com-
plex was detected. The identity of the protein(s) in this
faster mobility complex is unknown. However, it is un-
likely to contain EBF since EBF mRNA is not detected in
the macrophage line (see Fig. 3 A). The macrophage nu-
clear extract did contain Pax-5 binding activity, although
the amount of binding was approximately fivefold less than
that detected in the pre-B cell extract (Fig. 1 A). Equiva-
lent amounts of Octamer binding activity were detected in
extracts from both lines (Fig. 1 A). Therefore, the progres-
sion of 70Z/3 pre-B lymphocytes to the macrophage phe-
notype is associated with a loss of E2A and EBF DNA
binding activity and a reduction in Pax-5.
The absence of a mE5-binding complex in the macro-
phage line could result from a decrease in the amount of
E2A proteins or an increase in the expression of an Id pro-
tein, which have been shown previously to be expressed in
myeloid cells (39, 40, 41, 42, 43). Preliminary RT-PCR
analysis and Northern blot assays demonstrated that mRNA
encoding Id1, Id3, and Id4 were not expressed in 70Z/3
macrophages; however, Id2 mRNA could be detected
(data not shown). To determine whether Id2 protein was
present in the macrophage or pre-B lines, cells were labeled
with [35S]methionine and Id2 was immunoprecipitated
from total cellular extracts using a polyclonal anti-Id2 anti-
body. Id2 could be immunoprecipitated from the mac-
rophage, but not the pre-B cell extracts (Fig. 1 B). No Id2
was immunoprecipitated with a nonspecific control antise-
rum (data not shown). Western blot analysis demonstrated
that the amount of E12 and E47 protein was decreased at
least 10-fold in nuclear extracts from the macrophage line
as compared with the pre-B cell line (Fig. 1 C). These data
indicate that the decrease in mE5 binding activity observed
in the macrophage nuclear extract can be attributed to a
decrease in the expression of E2A proteins and an increase
in expression of Id2.
Ectopic Expression of E12 in the 70Z/3 Macrophage Cell
Line Leads to a Decrease in Mac-1, an Increase in Surface m, and
Induction of k Light Chain in Response to Mitogen. The in-
creased level of Id2 and decreased level of the E2A proteins
in the macrophage line are consistent with the hypothesis
that E2A is a major contributor to the B lineage pheno-
type. To test this hypothesis directly we stably transfected
the macrophage line with constructs encoding human E12
or neomycin under the control of the b-actin promoter
(pHbAPneo; reference 54). Greater than 25 neomycin-
expressing macrophage clones have been examined, all of
which resemble the parental macrophage clone. In con-
trast, greater than 15 E12-expressing macrophage clones
have been isolated all of which have demonstrated a similar
phenotype to the three representative E12-expressing mac-
rophage clones, 2C1, 2C6, and D3 described here. Each
of the E12-expressing macrophage clones expressed levels
of mE5 binding activity comparable to, or higher than,
that of the 70Z/3 pre-B cell line (see Fig. 3 C). All of the
mE5 binding activity in these clones was supershifted with
an antibody specific for human E2A or E12 and flow cyto-
metric analysis indicated that essentially all of the cells in
each clone expressed the human E12 protein (data not
shown).
A number of B lineage- or macrophage-associated traits
have been identified that distinguish the 70Z/3 pre-B and
macrophage cell lines (56, 64). The macrophage line is ir-
regular in shape and adherent to plastic whereas the major-
ity of pre-B cells are round and nonadherent. Interestingly,
the E12-expressing macrophage clones were less adherent
and more rounded than the parental macrophage line. Ap-
proximately 40–50% of the cells in each of the E12-
expressing lines were nonadherent, whereas ,15% of the
cells in the parental line, or the neomycin-expressing
clones, were nonadherent (data not shown). The macro-
phage and pre-B cell lines also differ in the expression of
the myeloid adhesion protein Mac-1 (CD11b/CD18).
Figure 1. A reduction in E2A, EBF and Pax-5 DNA binding activity is associated with the transition of 70Z/3 pre-B cells to the macrophage pheno-
type. (A) Electrophoretic mobility shift analysis of nuclear extracts prepared from the 70Z/3 pre-B (B) and macrophage (M) cell lines. 10 mg of nuclear ex-
tract was incubated with a 32P-labeled oligonucleotide probe containing an E2A- (mE5), EBF-, Pax-5–, or Oct-binding site. The extracts were incubated
in the absence (2) or presence of a 100-fold excess of specific (S) or nonspecific (N) competitive oligo. Arrows indicate the specific DNA-binding com-
plexes corresponding to E2A, EBF, Pax-5, or Oct-1. Two complexes are expected with Pax-5 oligo that contains both a Pax-5– and ets-binding site (52).
(B) Immunoprecipitation of Id2 from 35S-methionine–labeled 70Z/3 pre-B (B) and macrophage (M) cell lines. (C) Western blot analysis of 70Z/3 pre-B
(B) and macrophage (M) nuclear extracts. E2A proteins were detected with an anti-E12 (mAb 382.1) or anti-E47 (mAb 32.1) monoclonal antibody.703 Kee and Murre
Mac-1 expression can be detected on the surface of the
macrophage but not the pre-B cell line (64). Surprisingly,
FACSÒ analysis revealed that the E12-expressing macro-
phage lines ceased to express Mac-1 (Fig. 2, top). By con-
trast, all the neomycin-expressing macrophage clones ex-
pressed Mac-1 (Fig. 2 and data not shown).
The 70Z/3 pre-B and macrophage cell lines also dem-
onstrate distinct responses to the bacterial mitogen li-
popolysaccharide (LPS; reference 64). The pre-B cell line
responds to LPS by induction of its rearranged k light chain
and upregulation of the level of surface m (65). In contrast,
the macrophage line does not induce k or m in response to
LPS (56). Remarkably, each E12-expressing macrophage
clone was shown to induce k in response to LPS by flow
cytometry (Fig. 2, bottom). Greater than 90% of the cells in
the 2C1 and 2C6 clones and 30% of the D3 cells were k
inducible. A similar proportion of cells in each clone dem-
onstrated induction of m (Fig. 2, middle). Furthermore, ex-
pression of m was detected on the surface of these cells be-
fore LPS stimulation, a characteristic of the pre-B cell line
but not the parental or neomycin-expressing macrophage
lines.
We have observed a degree of variability in the ability of
independent clones to induce k that is not correlated with
the level of expression of E12. Interestingly, a similar de-
gree of variability (ranging from 20 to 80%) has been ob-
served in subclones of the parental 70Z/3 pre-B line
(Paige, C.J., personal communication). This finding sug-
gests that the variation in k induction observed in our E12-
expressing macrophage clones is likely due to an inherent
variation in the response to LPS in the parental line. Re-
gardless, we have found that expression of E12, but not
neomycin, in this macrophage line was sufficient to restore
the ability of some cells in each clone to induce k light
chain and m in response to LPS. Moreover, these alter-
ations in cell surface phenotype suggest that the E12-
expressing macrophage clones were losing the characteris-
tics of the macrophage lineage and acquiring those associ-
ated with pre-B lymphocytes.
Expression of E12 in the 70Z/3 Macrophage Line Results in
the Induction of EBF and Multiple B Lineage–associated
Genes. To further investigate the effects of E12 in the
70Z/3 macrophage line we examined the expression of a
number of B lineage genes by Northern blot analysis. High
levels of mRNA encoding EBF, l5, and IL7Ra were evi-
dent in all of the E12-expressing macrophage clones (Fig. 3
A) By contrast, neither the parental macrophage, nor the
neomycin clones, expressed significant levels of these mRNAs
(Fig. 3 A). In addition, Pax-5 transcripts were induced sig-
nificantly in the E12-expressing lines, although low levels
of Pax-5 can be detected in the parental macrophage line
indicating that E12 is not required for Pax-5 expression
(Fig. 3 A). None of these genes have been shown previ-
ously to be induced upon expression of E12, or E47, in
non-B lineage cells. However, Rag-1 and Rag-2 were up-
regulated after expression of E47 in a pre-T cell line (66,
67). Therefore, we also examined our clones for the ex-
pression of mRNA encoding Rag-1 and Rag-2 using a
sensitive RT-PCR assay. Neither the 70Z/3 pre-B nor
macrophage lines expressed Rag-1 by this analysis (Fig. 3
B). In contrast, each of the E12-expressing macrophage
clones expressed significant levels of Rag-1 mRNA (Fig. 3
B). None of the lines tested demonstrated detectable ex-
pression of Rag-2 mRNA (data not shown). By compari-
son, each of the lines expressed a similar amount of the
Ikaros gene, as determined by PCR primers that recognize
a COOH-terminal portion of the gene common to all
Ikaros isoforms (55; Fig. 3 B).
To determine whether the increase in mRNA observed
in the E12-expressing macrophage lines translated into an
Figure 2. E12-expressing mac-
rophage clones cease to express
Mac-1 and respond to LPS by
induction of k light chain and m.
The 70Z/3 pre-B, macrophage,
m/neo, and the E12-expressing
macrophage cell lines, 2C1, 2C6,
and D3 were examined by flow
cytometry for the expression of
the myeloid associated marker
Mac-1 (top). The shaded histo-
gram represents specific Mac-1
staining; open histograms repre-
sent staining in the presence of a
nonspecific control antibody.
Flow cytometric analysis of m
(middle) or k (bottom) expression
on the indicated cell lines after
incubation for 36 h in the pres-
ence (shaded histogram) or absence
(open histogram) of LPS. The his-
togram outlined with a dashed
line represents staining in the
presence of an isotype control
antibody.704 Induction of B Lineage Genes by E12
increase in protein for EBF and Pax-5 we tested nuclear
extracts prepared from each of these clones for binding to
specific DNA probes by EMSA. Each E12-expressing mac-
rophage clone demonstrated an increase in binding to the
EBF probe as compared with the parental or neomycin-
expressing macrophage clones (Fig. 3 C). The E12-express-
ing clones generally demonstrated two or three specific
complexes binding to the EBF probe which could also be
detected in extracts from the pre-B cell line with a longer
exposure. These slower migrating complexes are presumed
to be higher order multimers as has been suggested previ-
ously (45). Nuclear extracts from the E12-expressing clones
were also examined for the presence of proteins able to
bind to a Pax-5–binding site. Two of the clones, 2C1 and
D3, demonstrated an increase in Pax-5 binding compared
with the parental macrophage line. However, the 2C6 line
demonstrated binding comparable to that observed in the
parental macrophage, but greater than that observed in the
neomycin-expressing macrophage clone (Fig. 3 C). We
have found a significant variation in the amount of Pax-5
binding between individual neomycin-expressing mac-
rophage clones (compare the macrophage extract to the
neomycin-expressing macrophage extract in Fig. 3 C).
However, none of the neomycin-expressing clones have
demonstrated an increase in binding to the Pax-5 probe
compared with the parental macrophage line (data not
shown). The source of this variability remains to be eluci-
dated. However, at the present time it is difficult to deter-
mine whether the level of Pax-5 binding in the 2C6 clone
is increased from that in the individual cell that was trans-
fected. Regardless, the mRNA encoding EBF and Pax-5
is clearly upregulated in all E12-expressing macrophage
clones.
We also examined the expression of genes associated
with the myeloid lineage including the receptor for mac-
rophage colony-stimulating factor (c-fms), and Id2 by Nor-
thern blot analysis. The level of c-fms mRNA was reduced
3- to 20-fold in the E12-expressing macrophage clones
compared with the levels detected in the parental and neo-
mycin-expressing clones, although it was significantly
greater than that detected in the pre-B line (Fig. 3 A and
data not shown). By contrast, all of the E12-expressing
clones contained levels of Id2 mRNA that were similar to,
or slightly reduced compared with that observed in the pa-
rental and neomycin-expressing macrophage lines. Taken
together, our data demonstrate that expression of E12 in
this macrophage line was sufficient to induce a number of
B lineage–associated genes and is, furthermore, not incon-
sistent with the expression of some myeloid genes such as
c-fms. The observation that Id2 is not negatively regulated
by E12 is consistent with our identification of both Id2 and
E12 (and E47) mRNA in bipotent B cell/macrophage pro-
genitors (data not shown).
Induction of the B Lineage Phenotype in the Macrophage Line
Requires the Transactivation Domains of E12. The capacity of
E12 to activate transcription directly is less well established
than that for E47. E12 is not generally a major component
of E-box–binding complexes, a finding that is thought to
Figure 3. Increased expression of B lineage–associated genes in E12-
expressing macrophages. (A) Northern blot analysis of EBF, Pax-5, IL7Ra,
l5, c-fms, Id2, and actin mRNA expression. 10 mg of total RNA extracted
from the 70Z/3 pre-B, macrophage, m/neo, and the E12-expressing mac-
rophage clones 2C1, 2C6, and D3 was electrophoresed through an 0.8% aga-
rose gel and transferred to nylon membrane. The blots were probed sequen-
tially with 32P-labeled cDNA probes for the indicated genes. (B) RT-PCR
analysis of Rag-1 and Ikaros RNA expression. 2 mg of total RNA was re-
verse transcribed using an oligo dT15 primer in the presence (1) or absence
(2) of RT. 100 ng of cDNA was used for PCR amplification with primers
specific for Rag-1 (25 cycles), the COOH-terminal domain of Ikaros (25 cy-
cles), or actin (13 cycles; C) mE5, EBF, Pax-5, and Oct DNA binding activity
in E12-expressing macrophage cell lines. 10 mg of nuclear extract from each
of the indicated cell lines was incubated with a 32P-labeled oligonucleotide
probe containing the binding site for E2A (mE5), EBF, Pax-5, and Oct.705 Kee and Murre
be due to the presence of an inhibitory domain which low-
ers the affinity of E12 for its DNA-binding site (68). It is
possible that E12 may function to sequester Id from other
bHLH proteins, thereby allowing those factors to activate
transcription. Alternatively, the bHLH domain of E12 may
interact with other proteins that alter its transactivation po-
tential, as has been demonstrated for the bHLH domain of
MyoD (69, 70). To gain insight into the mechanism by
which E12 regulates the expression of EBF and other
B lineage–associated genes we created stable macrophage
lines expressing the E12 bHLH domain, but lacking the
transactivation domains (71, 72). All 15 neomycin-resistant
clones tested expressed levels of the E12 bHLH protein
comparable to, or higher than, that of our E12-expressing
macrophage clones as determined by FACSÒ and Western
blot analysis (data not shown). Three of these clones 2B4,
3C3, and 3D2 were chosen for further analysis.
The bHLH-expressing macrophage lines differed dra-
matically from the E12-expressing macrophage lines. The
bHLH-expressing lines remained adherent to plastic and ir-
regular in shape similar to the parental macrophage line
(data not shown). In addition, Mac-1 expression could be
detected on these cells by flow cytometry (Fig. 4, top).
Moreover, we found that the bHLH-expressing macro-
phage lines failed to induce m or k in response to LPS (Fig.
4, middle and bottom). Each of the bHLH-expressing clones
demonstrated high levels of mE5 binding activity as mea-
sured by EMSA (Fig. 5 A), indicating that the failure to ac-
tivate B lineage traits is not due to an inability to dimerize
or bind DNA. Therefore, our data indicate that the bHLH
domain alone, in the absence of the NH2-terminal transac-
tivation domains, is unable to induce these B lineage char-
acteristics in the 70Z/3 macrophage line.
To determine whether the transactivation functions of
E12 were required for the induction of other B lineage
genes RNA was prepared from the bHLH-expressing mac-
rophage lines and examined by Northern blot or RT-PCR
analysis. Remarkably, neither EBF nor Rag-1 mRNA
were detected in the bHLH-expressing clones (Fig. 5, B
and C). In addition, the level of Pax-5 mRNA remained
low in all bHLH clones, similar to the macrophage line
(Fig. 5 B). Therefore, the induction of EBF, Pax-5, and
Rag-1 in the E12-expressing macrophage cell lines also is
dependent on the transactivation functions of E12.
Surprisingly, expression of IL7Ra and l5 were detected
in the bHLH-expressing macrophage clones (Fig. 5 B).
This result was unexpected and may indicate that E12
functions by distinct mechanisms to regulate the expression
of different genes. Consistent with this notion, the DNA
binding domain of both MyoD and Pax-5 have been
shown to be sufficient to activate expression of a subset of
MyoD and Pax-5 target genes (73, 74). However, in our
experiments the level of mRNA detected for either IL7Ra
or l5 was highly variable and generally much lower than
that observed in the E12-expressing clones. This observa-
tion suggests that the presence of the E12 transactivation
domains facilitates expression of these genes. In this regard
it should be noted that some E47:E12 bHLH heterodimer
was detected in these cells which may provide a low level
of transactivation capacity (Fig. 5 A and data not shown).
Therefore, although the bHLH domain alone may be suffi-
cient for activation of IL7Ra and l5, it is also conceivable
that the threshold for activation of these genes is lower than
for other B lineage targets and therefore effected by low
levels of mixed heterodimers. Further studies will be re-
quired to determine the mechanism by which the bHLH
domain activates the IL7-Ra and l5 genes.
Ectopic Expression of EBF in the 70Z/3 Macrophage Line
Leads to the Activation of a Subset of E12 Inducible Traits.
Both E2A and EBF are obligatory for the proper develop-
ment of B lineage cells (18–20). Our data suggest that, in
the 70Z/3 macrophage line, one of the transcriptional tar-
gets of E12 is EBF. This raises the question as to how much
of the B lineage phenotype induced by E12 in this mac-
Figure 4. E12 bHLH-expressing macro-
phage clones express Mac-1 but fail to respond
to LPS by induction of k light chain and m. The
E12-expressing 2C1 line, m/neo, and three
E12 bHLH-expressing macrophage lines 2B4,
3C3, and 3D2 were examined by flow cytome-
try for the expression of the myeloid associated
marker Mac-1 (top). The shaded histogram rep-
resents specific Mac-1 staining, open histograms
represent staining in the presence of a nonspe-
cific control antibody. Flow cytometric analysis
of m (middle) or k (bottom) expression on the in-
dicated cell lines after incubation in the pres-
ence (shaded histogram) or absence (open histo-
gram) of LPS for 36 h. The histogram outlined
with a dashed line represents staining in the
presence of an isotype control antibody.706 Induction of B Lineage Genes by E12
rophage line is due to the activity of EBF. To address this
question, we created stable macrophage clones expressing
the rat Olf/EBF gene under the control of the b-actin pro-
moter. We identified five clones that expressed Olf/EBF
mRNA of the predicted size (2.1 kb) from the rat Olf/EBF
expression vector by Northern blot analysis. Three of these
clones, 2A3, 4B6, and 3D2 were selected for further analysis.
The EBF-expressing macrophage clones were found to
exhibit a decrease in plastic adherence such that 50–70% of
the cells were nonadherent, similar to the phenotype of the
E12-expressing clones (data not shown). However, unlike
the E12-expressing lines, the myeloid associated marker
Mac-1 could be detected on the EBF-expressing macro-
phages, although the levels of Mac-1 have been decreasing
gradually with time in culture (Fig. 6, top). To our surprise,
these EBF-expressing clones did demonstrate an increase in
the level of m as determined by flow cytometric analysis
(Fig. 6, middle). Moreover, some cells in each clone dem-
onstrated the capacity to induce k light chain and m in re-
sponse to LPS (Fig. 6, bottom and middle). These observa-
tions suggest that indeed, EBF alone is able to induce some
of the B lineage traits observed in the E12-expressing mac-
rophage lines.
To further investigate the ability of EBF to induce B lin-
eage–associated traits we examined the expression of B lin-
eage genes by Northern blot analysis. As expected, the
mRNA encoding Olf/EBF in each of the transfected
clones was 2.1 kb, as compared with 5.2–5.8 kb for the en-
dogenous gene. The larger transcripts that hybridize to the
Olf/EBF probe appear to be transcripts that fail to termi-
nate at the polyadenylation sequences 39 of the Olf/
EBF gene in the pHbAPneo expression vector (data not
shown). Overall, the level of Olf/EBF mRNA expressed in
these clones was found to be as high, or higher than, that in
the 70Z/3 pre-B– or E12-expressing macrophage clones
(note that the decreased level of actin mRNA for the 2A3
line; Fig. 7 A). Remarkably, each of the EBF-expressing
macrophage clones demonstrated an increase in the expres-
sion of Pax-5 and l5 mRNA, although l5 was expressed at
a lower level than that seen with E12 (Fig. 7 A). In con-
trast, EBF did not induce a significant increase in IL7Ra
(Fig. 7 A) or Rag-1, as determined by RT-PCR analysis
(Fig. 7 B). Therefore, expression of EBF in the 70Z/3
macrophage line results in the activation of a subset of E12-
inducible genes.
We examined the ability of EBF to induce E2A by
EMSA. Nuclear extracts from the EBF-expressing mac-
rophages did not demonstrate an increase in the level of
mE5-binding complexes (Fig. 7 C). The slight increase in
mE5-binding complex was within the range observed in
our panel of 25 neomycin-expressing clones and was there-
fore unlikely to be due to the expression of EBF (data not
shown). In addition, no differences in the amount of E12
or E47 protein were detected by Western blot analysis of
nuclear extracts prepared from EBF- or neomycin-express-
ing macrophage clones (data not shown). In contrast, an in-
crease in binding to the Pax-5 probe could be detected in
two of the EBF-expressing lines consistent with the increase
in Pax-5 mRNA (Fig. 7 C). Surprisingly, the amount of
EBF oligo shifted by EMSA was significantly lower than that
in the 2C1 line (Fig. 7 C). We estimate that the amount of
EBF binding to the EBF probe by EMSA is between two-
and sixfold lower than that observed in the 70Z/3 pre-B line
(compare 2C1 to 70Z/3 pre-B in Fig. 3 C). This estimate is
consistent with the level of expression observed by others af-
ter transfection of EBF into Ba/F3 cells (47). However, we
have found it difficult to quantify the amount of EBF since
binding to the EBF oligo, in our EMSA, does not appear to
be linearly related to the concentration of EBF in the extract.
In the absence of an EBF-specific antibody we were unable
to determine whether all of the cells in each clone expressed
EBF, however, the phenotype of the EBF-expressing mac-
rophage clones suggests that sufficient levels of EBF are ex-
Figure 5. The transactivation
domains of E12 are required for
activation of most B lineage
genes. (A) EMSA of mE5-bind-
ing complexes in 70Z/3 pre-B,
macrophage and three E12 bHLH-expressing macrophage clones 2B4,
3C3 and 3D2 (which lack the transactivation domains). All lanes are from
the same gel, however the pre-B and macrophage panel was exposed for
threefold longer than the 2B4, 3C3 and 3D2 lanes. The position of the
full-length E2A and E12 bHLH-binding complexes are indicated with an
arrow on the left side of the figure. (B) Northern blot analysis of EBF,
Pax-5, IL7Ra, l5, and actin expression in E12 bHLH-expressing mac-
rophage clones. 10 mg of total RNA from each of the cell lines was elec-
trophoresed through an 0.8% agarose gel and transferred to nylon mem-
brane. For comparison an E12-expressing (2C1) and neomycin expressing
(m/neo3) macrophage clone run on the same gel, are shown. The blots
were probed sequentially with 32P-labeled cDNA probes for the indicated
genes. The blot was probed with actin to demonstrate that similar
amounts of RNA were loaded in each lane. (C) RT-PCR analysis of
Rag-1 and actin RNA expression in the E12 bHLH-expressing macro-
phage clones. 2 mg of total RNA was reverse-transcribed using an oligo
dT15 primer in the presence (1) or absence (2) of RT. 100 ng of cDNA
was used for PCR amplification with primers specific for Rag-1 (25 cy-
cles) or actin (13 cycles).707 Kee and Murre
pressed to mediate gene activation in these cells. At the
present time we can not exclude the possibility that an in-
crease in the amount of EBF may have led to activation of
additional B lineage genes.
We also examined the EBF-expressing macrophage clones
for mRNA encoding the myeloid associated genes c-fms
and Id2, by Northern blot analysis. Unlike the E12-express-
ing clones, the EBF clones did not show a decrease in the
expression of c-fms (Fig. 7 A). We did detect a two- to
threefold decrease in the level of Id2 expression; however,
this was also observed in a few of our neomycin transfected
macrophage clones suggesting that this decrease was not
the result of EBF expression directly (data not shown). The
pattern of B lineage–associated traits detected in the E12-
or EBF-expressing macrophage lines is summarized in Ta-
ble 1. Taken together, our data indicate that, in the context
of this macrophage cell line, EBF was able to regulate a
subset of E12-inducible traits including expression of l5,
Pax-5, and responsiveness of k light chain to LPS. These
observations suggest that one of the critical functions of
E12 may be to activate EBF and together these factors co-
ordinately regulate multiple B lineage–associated genes.
Discussion
The progression of hematopoietic progenitors through
the earliest detectable stage of B cell development requires
the activity of the transcription factors encoded by the E2A
and EBF genes (18, 19, 20). The absence of B lineage cells
in mice that lack these genes has made it difficult to exam-
ine the role of each factor in promoting, or maintaining,
the B lineage developmental program. In this paper we
have described a novel cell line model in which the role of
the E2A and EBF proteins in regulating the expression of B
lineage traits can be studied. We have shown that the spon-
taneous loss of B lineage genes from the 70Z/3 pre-B cell
line is associated with a loss of E2A and EBF DNA binding
activity. Moreover, expression of the E2A protein E12 in
this macrophage line results in the induction of a large
number of B lineage traits including mRNA encoding
EBF, Pax-5, l5, IL7Ra, and Rag-1, and the ability to acti-
vate k light chain in response to LPS. Our data indicate
that activation of EBF may be one of the functions of E12
in regulating the B lineage phenotype in these cells. This
hypothesis is supported by the finding that ectopic expres-
sion of EBF in the macrophage line results in the activation
of a subset of E12-induced genes including Pax-5, l5, and
k light chain responsiveness to LPS, but not expression of
E2A, IL7Ra, or Rag-1. Taken together, our data suggest,
that in the hierarchy of transcription factors regulating B
cell development, E12 functions upstream of EBF. How-
ever, E12 may interact with EBF or Pax-5 to regulate ex-
pression of B lineage genes during B cell development.
The ability of E12 to activate most B lineage traits is de-
pendent on the amino-terminal transactivation domains
suggesting that E12 does not function by releasing an alter-
native bHLH protein from inhibition by Id2. Furthermore,
the requirement for the transactivation domains suggest
that E12 does not function in a manner analogous to the
myogenic bHLH protein MyoD. The bHLH domain
alone of MyoD has been shown to be sufficient for the ac-
tivation of muscle-specific genes and the induction of the
myogenic program (75). Recent studies have shown that
the MyoD bHLH domain is able to interact with a muscle-
specific transcription factor, MEF2, and together these pro-
teins demonstrate a transactivation potential that is not
found in either protein alone (70). In addition, a novel
MyoD domain, NH2-terminal to the basic region, has re-
cently been implicated in the remodeling of chromatin
thereby leading to increased activation of the myogenin
promoter (73). The bHLH domain of E2A is able to inter-
act with p300/CBP (creb-binding protein) which associ-
ates with a histone acetyltransferase activity and could,
therefore, mediate chromatin restructuring in a manner
Figure 6. EBF-expressing macrophage
lines express Mac-1 and respond to LPS by
induction of k light chain and m. The 2C6,
m/neo 6 (a neomycin-expressing macro-
phage), and 3 EBF-expressing macrophage
cell lines, 2A3, 4B6, and 3D4 were examined
by flow cytometry for the expression of the
myeloid-associated marker Mac-1 (top). The
shaded histogram represents specific Mac-1
staining, open histograms represent staining
in the presence of a nonspecific control an-
tibody. Flow cytometric analysis of m (mid-
dle) or k (bottom) expression on the indicated
cell lines after incubation for 36 h in the
presence (shaded histogram) or absence (open
histogram) of LPS. The histogram outlined
with a dashed line represents staining in the
presence of an isotype control antibody.
The 70Z/3 pre-B, macrophage, m/neo,
and the E12-expressing macrophage cell
lines, 2C1, 2C6, and D3 were examined by
flow cytometry for the expression of the
myeloid associated marker Mac-1 (top).708 Induction of B Lineage Genes by E12
analogous to that of MyoD (76, 77). Such a mechanism
may contribute the activation of the IL7Ra and l5 genes
observed in the bHLH domain only expressing lines. How-
ever, the low level of activation observed in the presence of
very high levels of bHLH protein suggest that the transacti-
vation domains of E12 also contribute significantly to ex-
pression of these genes (see Fig. 5). Taken together, our
data suggest that the transactivation domains of E12, or ad-
ditional sequences found in the NH2-terminal domain, are
required for the activation of the majority of B lineage as-
sociated traits in the 70Z/3 macrophage cell line.
Our studies provide the first demonstration of activation
of the endogenous EBF gene in response to expression of
E12. The finding that EBF is a downstream target of E12
was somewhat surprising given that EBF expression can be
detected, at very low levels, in the fetal liver and bone mar-
row of E2A-deficient mice (18, 29). This discrepancy can
be accounted for in at least one of two ways. First, EBF is
expressed in adipocytes as well as B lineage cells (45).
Therefore, the low level of EBF observed in E2A-deficient
mice may be the result of expression in non-B lineage cells.
Second, two additional bHLH transcription factors, HEB
and E2-2, are expressed in B cell progenitors. These tran-
scription factors bind to the same DNA sequence as the
E2A proteins and play an important, although nonessential,
role in B lymphopoiesis (78). It is possible that in the ab-
sence of E2A, HEB or E2-2 can regulate the expression of
EBF. Alternatively, the regulation of EBF by E12 may be
unique to this cell line. Although E12 is able to regulate the
expression of EBF in the context of this macrophage line it
appears that this is not its sole function in regulating B lin-
eage progression since expression of EBF alone does not
result in the activation of all of the genes induced by E12.
Ectopic expression of either E12 or EBF lead to an in-
crease in mRNA encoding the B lineage–associated tran-
scription factor Pax-5. Surprisingly, expression of Pax-5
was not completely extinguished during the conversion of
70Z/3 pre-B lymphocytes to the macrophage phenotype
indicating that neither factor is required for the continued
expression of this gene. Interestingly, it has been suggested
that the Pax-5 gene is a target of the IL7R signaling cascade
(79), yet we find expression of Pax-5 in the macrophage
line and an upregulation of Pax-5 transcripts in EBF-
expressing clones that do not express IL7R transcripts. Al-
though expression of the IL7R itself may not be required
for Pax-5 expression in these cells, our data do not exclude
the possibility that Pax-5 is a target of the transcription fac-
tors that are activated by the IL7R signaling cascade. Re-
cent studies have demonstrated that gene regulation by
Pax-5 is exquisitely sensitive to the cellular concentration
of this protein (80). Accordingly, the threefold decrease in
Pax-5 DNA binding activity observed in the macrophage
line may have a dramatic effect on the expression of Pax-5
target genes. Pax-5 functions as a repressor of some genes,
such as the immunoglobulin J chain, and an activator of
others, such as CD19 (81, 82). The affinity of a given Pax-
5–binding site, its context within the promoter and the rel-
ative concentration of Pax-5 have all been postulated to
contribute to the ability of Pax-5 to activate or repress a
given gene (80). In our clones it is possible that the low
level of Pax-5 observed in the parental macrophage clone is
sufficient to synergize with the transfected E12 or EBF to
activate genes that may not have been successfully activated
by either transcription factor alone. Similarly, the increased
level of Pax-5 observed in E12- or EBF-expressing mac-
rophage clones is likely to contribute to the pattern of gene
activation in these clones.
The induction of k light chain in pre-B cell lines has been
associated with the activation of at least three distinct DNA
binding activities within the k enhancer, NF-kB, Oct-2, and
KBF-A in addition to E2A (83–86). We have found no dif-
Figure 7. Expression of a sub-
set of B lineage genes in EBF-
expressing macrophage cell lines.
(A) Northern blot analysis of
EBF, Pax-5, IL7Ra, l5, c-fms,
Id2, and actin mRNA expres-
sion. 10 mg of total RNA ex-
tracted from the EBF-expressing
macrophage cell lines 2A3, 4B6,
and 3D4 or from a neomycin-
or E12-expressing  macrophage
clone 2C1 was electrophoresed
through an 0.8% agarose gel and
transferred to nylon membrane.
The blots were probed sequen-
tially with 32P-labeled cDNA
probes for the indicated genes.
(B) RT-PCR analysis of Rag-1
and actin RNA expression. 2 mg
of total RNA was reverse-transcribed using an oligo dT15 primer in the
presence (1) or absence (2) of RT. 100 ng of cDNA was used for PCR
amplification with primers specific for Rag-1 (25 cycles), or actin (13 cy-
cles). (C) mE5, EBF, Pax-5, and Oct DNA binding activity in EBF-
expressing macrophage cell lines. 10 mg of nuclear extract from each of
the indicated cell lines was incubated with a 32P-labeled oligonucleotide
probe containing the binding site for E2A (mE5), EBF, Pax-5, and Oct.709 Kee and Murre
ferences in the ability of 70Z/3 pre-B cells and macrophages
to activate any of these factors in response to LPS (Kee, B.L.,
unpublished data). It was unexpected to find that expression
of EBF in the macrophage line led to the ability to induce k
in response to LPS. It is not certain whether this is the result
of EBF activity on the k locus itself, or whether EBF acti-
vates a B lineage–associated gene that influences k expres-
sion. However, binding sites for EBF have been identified in
the promoters of a number of k light chain genes within the
VkII and VkV families (87). The 59 flanking region of the k
gene expressed in 70Z/3 pre-B cells does contain a potential
EBF-binding site (88). EBF interaction with its binding site
in immature B cells has been suggested to lead to inhibition
of k gene expression (87). Therefore, it remains to be deter-
mined whether a modification of EBF in response to LPS
may relieve this repressive effect or whether k induction in
EBF-expressing clones is the result of a novel EBF-regulated
gene. In addition, it remains to be determined whether k in-
duction proceeds through the same pathway in E12- and
EBF-expressing lines since multiple combinations of en-
hancer binding proteins have been implicated in the regula-
tion of k transcription (86, 89, 90).
EBF and E47 have been shown previously to synergize
to activate the endogenous l5 and VpreB genes in Ba/F3
cells (47). Our results are consistent with these findings
since the level of l5 is greater in the E12-expressing clones,
which also express EBF, than in EBF only–expressing
clones. However, expression of EBF alone in this mac-
rophage line led to levels of l5 which were easily detected
by Northern blot analysis. We speculate that the ability of
EBF to activate l5 in this context, but not in Ba/F3 cells,
may be due to the presence of other B lineage factors, such
as Pax-5, in this cell line. The l5 promoter contains bind-
ing sites for E2A, EBF, Pax-5, and Ikaros proteins and it is
possible that any combination of these proteins might be
involved in the regulation of this gene. Our data also sug-
gest that in the context of this macrophage line EBF is not
absolutely required for l5 expression since the bHLH do-
main could activate low levels of l5 in the absence of EBF.
Expression of E12 in the 70Z/3 macrophage cell line led
to the expression of two genes, IL7Ra and Rag-1, which
were not induced significantly by expression of EBF. Al-
though EBF expression is not sufficient for the activation of
either of these genes, our results to not exclude the possi-
bility that EBF may play a role in their regulation or that
higher levels of EBF may have activated these genes. EBF
may function in the regulation of Rag genes in combina-
tion with E2A and/or Pax-5. However, it seems unlikely
that EBF is required for the activation of IL7Ra expression
during B cell development since we have found that ex-
pression of IL7Ra precedes the expression of EBF by at
least two days in cultures of lineage unrestricted B cell pro-
genitors differentiating in vitro (Kee, B.L., unpublished
data). In addition, expression of IL7Ra transcripts is less af-
fected in EBF-deficient mice than the expression of a num-
ber of additional B lineage associated genes (20). Further
studies will be required to determine whether the activity
of EBF is required for activation of these genes.
The 70Z/3 cell line is one of a number of B lineage lines
that are capable of losing some of their B cell characteristics
and acquiring characteristics of macrophages (56, 58, 59,
60–63, 91). However, 70Z/3 is unique in that it is one of
the few lines that undergoes this transition spontaneously in
vitro. Like most of the other lineage “switching” cell lines
70Z/3 macrophage cells have never shown reversion to the
B lineage phenotype, despite numerous attempts to identify
such revertants (64; Kee, B.L., unpublished data). There-
fore, it is particularly surprising that expression of a single
cDNA (E12 or EBF) can lead to the expression of such a
large number of B lineage genes in this macrophage line. In
addition, it is remarkable that the loss of E2A and EBF is
correlated with the loss of expression of such a large number
of B lineage–associated traits. We have examined two other
pre-B cell–derived macrophage cell lines, P388D1 and
Raw 309, for the expression of E2A and EBF and have
found that they also lack expression of both E2A and EBF
(Kee, K.L. unpublished data). This finding is consistent
with the hypothesis that loss of E2A and EBF are an essen-
tial feature of the transition of B lineage cells to the mac-
rophage phenotype. Unfortunately, our attempts to create
stable E12 expressing lines from these cells has been unsuc-
cessful, potentially owing to the ability of E2A proteins to
inhibit cell growth.
It is also piquant that the loss of the B lineage–associated
traits is associated with an increase in macrophage–like
characteristics. In general, each of the lineage switching B
cell lines has in common the expression of CD5, indicating
that they are derived from progenitors which originate dur-
ing fetal development (reviewed in reference 57). Some B
cell progenitors that develop during fetal life have been
shown to derive from a bipotent B cell and/or macrophage
progenitor (92). This finding is consistent with the hypoth-
esis that the genetic programs regulating the early B lineage
or macrophage differentiation programs may diverge by
only a few genetic events. Alternatively, macrophages may
Table 1. Summary of B Lineage Traits in 70Z/3 Pre-B, 
Macrophage and E12- or EBF-Expressing Macrophage Cell Lines
Cell lines
Pre-B Macrophage
Macrophages expressing
E12 bHLH EBF
E2A 111 2 111* 22
EBF 111 2 111 2 111*
Pax-5 111 1 111 1 111
l5 111 2 111 11 11
IL7Ra 111 2 111 11 2
Rag-1 2 2 111 2 2
k Induction 111 2 111 2 11
*Expression due to transfected construct.710 Induction of B Lineage Genes by E12
represent a default pathway that is followed in the absence
of lineage specifying genes. Future experiments will be
necessary to determine whether E2A proteins are involved
in the regulation of cell fate decisions of bipotent B cell/
macrophage progenitors or other lineage unrestricted B cell
progenitors.
It is interesting that targeted deletion of the majority of
the genes induced by E12 or EBF, such as l5, IL7Ra, and
Rag-1, leads to an arrest in B lymphopoiesis at a later de-
velopmental stage than that seen in E2A- or EBF-deficient
mice (7, 8, 11, 93–96). Therefore, novel targets of E2A or
EBF are likely to be required for progression through the
earliest stages of the B lineage pathway. This cell line
model provides a useful system by which to identify such
essential E2A and EBF target genes.
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